Significance of Circulating Plasma Cells in Multiple Myeloma

References

• Morissette L., Watkins C. H. Multiple myeloma: Diagnostic value of the blood smear. Proc. Mayo Clin. 1946; 17: 433–437
   Google Scholar
• Ginsberg D. M. Circulating plasma cells in multiple myeloma. A method for detection and review of the problem. Ann. Int. Med. 1962; 57: 843–846
   PubMed Web of Science ®Google Scholar
• Kyle R. A. Multiple myeloma; review of 869 cases. Mayo Clin. Proc 1975; 50: 29–50
   PubMed Web of Science ®Google Scholar
• Working M. R. C. party on leukaemia in adults. Prognostic features in the third myelomatosis trial. Br. J. Cancer 1980; 42: 831–840
   PubMed Web of Science ®Google Scholar
• Witzig T. E., Gonchoroff N. J., Katzmann J. A., Ther-Neau T. M., Kyle R. A., Greipp P. R. Peripheral blood B cell labeling indices are a measure of disease activity in patients with monoclonal gammapathies. J. Clin. Oncol. 1988; 6: 1041–1046
   PubMed Web of Science ®Google Scholar
• Witzig T. E., Gaston J., Gertz M., Kyle R. A., Lust J., Greipp P. R. The number of peripheral blood plasma cells distinguishes smoldering from active multiple myelome (Abstract). Proc. Am. Soc. Clin. Oncol. 1992; 11: 360
   Google Scholar
• Witzig T. E., Dhodapkar M. V., Kyle R. A., Greipp P. R. Quantification of circulating peripheral blood plasma cells and their relationship to disease activity in patients with multiple myeloma. Cancer 1993; 72: 108–113
   PubMed Web of Science ®Google Scholar
• Mellstedt H., Hammarstrom S., Holm G. Monoclonal lymphocyte population in human plasma cell myeloma. Clin. Exp. Immunol. 1974; 17: 371–377
   PubMed Web of Science ®Google Scholar
• Shimazaki C., Gotoh H., Oku N., Inaba T., Murakami S., Oku N., Itoh K., Ura Y., Nakagawa M., Fujita N. Detection of minimal residual myeloma cells by dual parameter analysis of DNA and cytoplasmic immunoglobulin. Acta Haematol. (Basel) 1991; 85: 20–25
   PubMed Web of Science ®Google Scholar
• Shimizu K., Murate T., Kunii A. Circulating immunoglobulin-secreting cells in patients with plasma cell dyscrasia. Blood 1980; 55: 590–594
   PubMed Web of Science ®Google Scholar
• Caligaris-Cappio F., Gregoretti M. G., Ghia P., Ber-Gui L. In vitro growth of human multiple myeloma: implications for biology and therapy. Hematol. Oncol. Clin. N. Am. 1992; 6: 257–271
   PubMed Web of Science ®Google Scholar
• Berenson J., Wong R., Kim K., Brown N., Lichten-Stein A. Evidence for peripheral blood B lymphocyte but not T lymphocyte involvement in multiple myeloma. Blood 1987; 70: 1550–1553
   PubMed Web of Science ®Google Scholar
• Van Riet I., Herman C., Lacor P., De Waele M., Thiele-Mans K., Van Camp B. Detection of monoclonal B lymphocytes in bone marrow and peripheral blood of multiple myeloma patients by immunoglobulin gene rearrangement studies. Br. J. Haematol. 1989; 73: 289–294
   PubMed Web of Science ®Google Scholar
• Billadeau D., Quam L., Thomas W., Kay M., Greipp P., Kyle R. A., Ohen M. M., Van Ness B. Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients. Blood 1992; 80: 1818–1824
   PubMed Web of Science ®Google Scholar
• King M. A., Wells J. V. Cell-bound immunoglobulin on peripheral blood mononuclear cells of patients with myeloma. Clin. Exp. Immunol. 1981; 45: 552–556
   PubMed Web of Science ®Google Scholar
• Lokhorst H. M., Boom S. E., Terpstra W., Roholl P., Gerdes J., Bast B. J. E. G. Determination of the growth fraction in monoclonal gammopathy with the monoclonal antibody Ki67. Br. J. Haematol. 1988; 69: 477–481
   PubMed Web of Science ®Google Scholar
• Wearne A. J., Joshua D. G., Brown R. D., Kronenberg H. Multiple myeloma: The relationship between CALLA (CD 10) positive lymphocytes in the peripheral blood and light chain isotype suppression. Br. J. Haematol. 1987; 67: 39–44
   PubMed Web of Science ®Google Scholar
• Osterborg A., Nilsson B., Bjokholm M., Holm G., Johansson B., Lindemalm C., Petterson D., Ahre A., Mells-Tedt H. Blood B cell excess at diagnosis in multiple myeloma: relation to prognosis. Eur. J. Haematol. 1987; 38: 173–178
   PubMed Web of Science ®Google Scholar
• Durie B. G. M., Salmon S. E. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival. Cancer 1975; 36: 842–849
   PubMed Web of Science ®Google Scholar
• Greipp P. R., Katzmann J. A., O'Fallon W. M., Kyle R. A. Value of beta-2 microglobulin level and plasma cell labeling indices as prognostic factors in patients with newly diagnosed myeloma. Blood 1988; 72: 219–223
   PubMed Web of Science ®Google Scholar
• Durie B. G. M., Stock-Novack D., Salmon S. E., Finley P., Beckord J., Crowley J., Coltman C. A. Prognostic value of pretreatment serum beta-2 microglobulin in myeloma: A Southwest Oncology Group Study. Blood 1990; 75: 823–830
   PubMed Web of Science ®Google Scholar
• Bataille R., Boccadoro M., Klein B., Durie B. G. M., Pileri A. C-reactive protein and beta-2 microglobulin produce a simple and powerful myeloma staging system. Blood 1992; 80: 733–737
   PubMed Web of Science ®Google Scholar
• Greipp P. R., Lust J. A., O'Fallon W. M., Katzmann J. A., Witzig T. E., Kyle R. A. Plasma cell labeling index and beta-2 microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma. Blood 1993; 81: 3382–3387
   PubMed Web of Science ®Google Scholar
• Barlogie B., Smallwood L., Smith T., Alexanian R. High serum levels of lactic deshydrogenase identify a high-grade lymphoma-like myeloma. Ann. Intern. Med. 1989; 110: 521–525
   PubMed Web of Science ®Google Scholar
• Ruiz Argiielles G. J., Katzmann J. A., Greipp P. R., Gon-Choroff N. J., Garton J. P., Kyle R. A. Multiple myeloma: Circulating lymphocytes that express plasma cell antigens. Blood 1984; 64: 352–356
   PubMed Web of Science ®Google Scholar
• Omedd P., Boccadoro M., Gallone G., Frieri R., Battaglio S., Redoglia V., Pileri A. Multiple myeloma: Increased circulating lymphocytes carrying plasma cell-associated antigens as an indicator of poor survival. Blood 1990; 76: 1375–1379
   PubMed Web of Science ®Google Scholar
• Pilarski L. M., Jensen G. S. Monoclonal circulating B cells in multiple myeloma: A continuously differentiating, possibly invasive, population as defined by expression of isoforms and adhesion molecules. Hematol. Oncol. Clin. N. Am. 1992; 6: 297–322
   PubMed Web of Science ®Google Scholar